Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC)
- 1 August 1997
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 20 (4), 528-538
- https://doi.org/10.1023/a:1005353530303
Abstract
The clbC form of methylmalonic acidaemia is a rare and poorly understood condition which results from impaired biosynthesis of methylcobalamin and adenosylcobalamin. The consequent functional deficiencies of methylmalonyl‐CoA mutase and methionine synthase produce both methylmalonic aciduria and homocystinuria. Systemic symptoms and neurological decompensation comprise the clinical phenotype. In an effort to clarify the phenotype and prognosis, we obtained clinical information on 50 patients with methylmalonic acidaemia whose cells had been assigned to the cblC complementation group. We identified two distinct phenotypes; they differed in age of onset, presence of systemic symptoms, type of neurological symptoms, and outcome after diagnosis and treatment. Forty‐four patients presented in the first year of life. Feeding difficulties, neurological dysfunction (hypotonia, seizures, developmental delay), and ophthalmological and haematological abnormalities characterized their clinical picture. About one‐quarter of those patients died. Survival was associated with neurological impairment; only one infant was neurologically intact at follow‐up. Onset in childhood, in contrast, was associated with less severe haematological abnormalities, largely involving the red cell series. Extrapyramidal signs, dementia, delirium or psychosis characterized the neurological findings. Survival, with mild to moderate disability in some, was typical in patients with later onset. Treatment in both groups included hydroxycobalamin, betaine and carnitine; complete normalization of biochemical parameters was rare.Keywords
This publication has 26 references indexed in Scilit:
- Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Biochemical diagnosis and outcome of 2 years treatment in a patient with combined methylmalonic aciduria and homocystinuriaEuropean Journal of Pediatrics, 1992
- Cobalamin C defect associated with hemolytic-uremic syndromeThe Journal of Pediatrics, 1992
- Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutationEuropean Journal of Pediatrics, 1992
- Methylmalonic aciduria with homocystinuria: Biochemical studies, treatment, and clinical course of a Cbl-C patientEuropean Journal of Pediatrics, 1990
- Inherited disorders of vitamin B12 metabolismBlood Reviews, 1987
- A Cobalamin Metabolic Defect with Homocystinuria, Methylmalonic Aciduria and Macrocytic Anemia*Neuropediatrics, 1986
- Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduriaThe Journal of Pediatrics, 1986
- Cobalamin C Mutation (Methylmalonic Aciduria and Homocystinuria) in AdolescenceThe New England Journal of Medicine, 1984
- Abnormal cobalamin metabolism in a megaloblastic child with homocystinuria, cystathioninuria and methylmalonic aciduriaJournal of Inherited Metabolic Disease, 1983